Transvaginal sacrospinous ligament fixation: Efficacy in treating pelvic prolapse and influence on patients’ anxiety and depression

Table 1 Comparison of baseline data between the two group, mean ± SD/ n (%)

Baseline data	Control group (n = 30)	Observer group (n = 30)	t/χ2 value	P value
Age (years)	59.23 ± 4.87	58.57 ± 4.16	0.564	0.575
Body mass index (kg/m2)	24.58 ± 2.93	24.39 ± 2.85	0.255	0.799
Previous pregnancy (times)	3.11 ± 0.75	3.07 ± 0.71	0.212	0.832
Parity (times)	2.14 ± 0.43	2.18 ± 0.46	0.348	0.729
Prolapse time (year)	3.28 ± 0.87	3.39 ± 0.92	0.476	0.636
Prolapse degree			0.601	0.438
Degree 3	17 (56.67)	14 (46.67)
Degree 4	13 (43.33)	16 (53.33)
Previous abdominal surgery			0.341	0.559
Have	7 (39.02)	9 (39.02)
Not have	23 (39.02)	21 (39.02)

Table 2 Comparison of perioperative observation indicators between two group, mean ± SD/ n (%)

Perioperative indicators	Control group (n = 30)	Observer group (n = 30)	t/χ2 value	P value
Surgical duration (minutes)	97.18 ± 19.45	114.43 ± 22.32	3.191	0.002
Intraoperative blood loss (mL)	89.54 ± 16.56	102.65 ± 17.84	2.950	0.004
Postoperative exhaust time (hours)	18.87 ± 1.29	19.18 ± 1.36	0.906	0.369
Postoperative pain intensity
VAS score on the 1st day after operation (points)	5.60 ± 1.05	6.21 ± 1.23	2.066	0.043
VAS score on the 7th day after operation (points)	2.18 ± 0.47	2.26 ± 0.37	0.733	0.467
Hospitalization time (days)	9.68 ± 1.23	9.59 ± 1.18	0.289	0.773
Postoperative complications
Vaginal Infection	1 (3.33)	2 (6.67)	0.351	0.554
Retention of urine	2 (6.67)	0 (0.00)	2.069	0.150
Bleeding	1 (3.33)	3 (10.00)	1.071	0.301

VAS: Visual Analog Scale.

Table 3 Comparison of prolapse distance between two group (cm), mean ± SD

Group	n	Anterior vaginal		Posterior vaginal		Top of vagina
		Preoperative	3 months after surgery	Preoperative	3 months after surgery	Preoperative	3 months after surgery
Control group	30	1.53 ± 0.36	-1.86 ± 0.43a	-1.28 ± 0.78	-2.17 ± 0.38a	1.52 ± 0.38	-2.94 ± 0.26a
Observer group	30	1.60 ± 0.38	-2.23 ± 0.37a	-1.33 ± 0.72	-2.46 ± 0.49a	1.63 ± 0.32	-3.11 ± 0.17a
t value		0.733	3.572	0.258	2.562	1.213	2.997
P value		0.467	0.001	0.797	0.013	0.230	0.004

^aP < 0.05 vs preoperative results within the group.

Table 4 Comparison of Female Sexual Function Index scores for sexual function before and after surgery in the two groups of patients, mean ± SD

Group	n	Preoperative	6 months after surgery
Control group	30	13.75 ± 3.18	22.54 ± 4.65a
Observer group	30	12.94 ± 3.05	26.21 ± 4.92a
t value		1.007	2.969
P value		0.318	0.004

^aP < 0.05 vs preoperative results within the group.

Table 5 Comparison of pelvic function between two group (score), mean ± SD

Group	n	PFDI-20 score		PFIQ-7 score
		Preoperative	6 months after surgery	Preoperative	6 months after surgery
Control group	30	73.54 ± 6.85	51.87 ± 4.61a	15.23 ± 2.65	12.78 ± 1.84a
Observer group	30	73.82 ± 6.93	47.76 ± 3.89a	14.95 ± 2.48	10.46 ± 1.79a
t value		0.157	3.732	0.423	4.950
P value		0.875	< 0.001	0.674	< 0.001

^aP < 0.05 vs preoperative results within the group.

PFDI-20: Pelvic Floor Dysfunction Inventory 20; PFIQ-7: Pelvic Floor Impact Questionnaire 7.

Table 6 Comparison of anxiety and depression scores between the two group (score), mean ± SD

Group	n	SAS score		SDS score
		Preoperative	6 months after surgery	Preoperative	6 months after surgery
Control group	30	65.65 ± 9.43	54.98 ± 6.59a	62.78 ± 8.15	51.25 ± 5.43a
Observer group	30	66.28 ± 9.67	47.21 ± 4.37a	63.19 ± 8.73	42.87 ± 4.86a
t value		0.256	5.382	0.188	6.299
P value		0.799	< 0.001	0.852	< 0.001

^aP < 0.05 vs preoperative results within the group.

SAS: Self-Rating Anxiety Scale; SDS: Self-Rating Depression Scale.